Islet Cell Therapy: Emerging Strategy to Treat Type 1 Diabetes
Availability
Registration Required
Online Meeting
Oct 30, 2026 3:00 PM - 4:00 PM ET
Cost
$0.00
Credit Offered
1 AMA PRA Category 1 Credit
1 ABIM-MOC Point
  • Course Description
  • Learning Objectives
The webinar will examine the mechanisms underlying T1D progression, recent advancements in islet cell therapy, and practical considerations for individualized, multidisciplinary care across the lifespan.

At the end of this session, participants will be able to:

  • Enhance understanding of the mechanisms leading to β-cell autoimmune reactivity and how they impact staging of presymptomatic T1D
  • Evaluate emerging islet cell therapies for the treatment of T1D and develop individualized care approaches to improve long-term quality of life
  • Foster collaboration among health care professionals in a multidisciplinary team to devise a holistic, consistent strategy for lifelong care in patients with T1D
   
     EndoCareers | Contact Us | Privacy Policy | Terms of Use CONNECT WITH US                
       © 2021 Copyright Endocrine Society. All rights reserved.
2055 L Street NW, Suite 600 | Washington, DC 20036      
 202.971.3636 | 888.363.6274
      
   
Android App Download IOS App Download Powered By